Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer

US Patent 9402846 · Granted Aug 2, 2016

Estimated economic value: $10,842,000

Assignee

Inventors

View full patent text on Google Patents →